CHG

514

+3.21%↑

CHG

514

+3.21%↑

CHG

514

+3.21%↑

CHG

514

+3.21%↑

CHG

514

+3.21%↑

Search

Halma PLC

Închisă

SectorSectorul industrial

3,612 2.44

Rezumat

Modificarea prețului

24h

Curent

Minim

3526

Maxim

3618

Indicatori cheie

By Trading Economics

Venit

107M

187M

Vânzări

651M

1.2B

P/E

Medie Sector

39.055

48.817

EPS

0.553

Randament dividend

0.67

Marjă de profit

15.096

Angajați

9,000

EBITDA

184M

317M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+5.88% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.67%

2.06%

Statistici piață

By TradingEconomics

Capitalizare de piață

-370M

13B

Deschiderea anterioară

3609.56

Închiderea anterioară

3612

Sentimentul știrilor

By Acuity

10%

90%

14 / 408 Clasament în Industrials

Halma PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 feb. 2026, 17:25 UTC

Achiziții, Fuziuni, Preluări

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9 feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9 feb. 2026, 23:43 UTC

Market Talk

Gold Falls on Possible Technical Correction -- Market Talk

9 feb. 2026, 23:14 UTC

Market Talk

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9 feb. 2026, 22:29 UTC

Market Talk

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9 feb. 2026, 22:19 UTC

Market Talk

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9 feb. 2026, 22:08 UTC

Market Talk

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9 feb. 2026, 22:01 UTC

Câștiguri

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9 feb. 2026, 21:59 UTC

Câștiguri

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9 feb. 2026, 21:59 UTC

Câștiguri

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9 feb. 2026, 21:58 UTC

Câștiguri

Friedman Industries 3Q Sales $168M >FRD

9 feb. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

9 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 feb. 2026, 21:48 UTC

Câștiguri

Friedman Industries 3Q EPS 43c >FRD

9 feb. 2026, 21:17 UTC

Câștiguri

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9 feb. 2026, 21:13 UTC

Market Talk

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9 feb. 2026, 21:04 UTC

Câștiguri

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9 feb. 2026, 20:30 UTC

Market Talk

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9 feb. 2026, 20:02 UTC

Market Talk

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9 feb. 2026, 19:42 UTC

Market Talk

Japan's Yield Curve Expected to Flatten -- Market Talk

9 feb. 2026, 19:31 UTC

Market Talk

Nike Seen Regaining Relevance With Consumers -- Market Talk

9 feb. 2026, 19:27 UTC

Market Talk

Gold Climbs Back Over $5,000/oz -- Market Talk

9 feb. 2026, 19:05 UTC

Market Talk

Nike Returns to List of Hottest Brands -- Market Talk

9 feb. 2026, 18:19 UTC

Market Talk

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9 feb. 2026, 17:41 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 feb. 2026, 17:31 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 feb. 2026, 17:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

9 feb. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 feb. 2026, 17:17 UTC

Market Talk

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9 feb. 2026, 17:16 UTC

Câștiguri

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Comparație

Modificare preț

Halma PLC Așteptări

Obiectiv de preț

By TipRanks

5.88% sus

Prognoză pe 12 luni

Medie 3,756.56 GBX  5.88%

Maxim 4,200 GBX

Minim 2,490 GBX

În baza a 13 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHalma PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

13 ratings

7

Cumpărare

5

Păstrare

1

Vânzare

Sentiment

By Acuity

14 / 408 Clasament în Sectorul industrial

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat